Victory Capital Management Inc Avenue Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$8.29 - $11.47 $10,287 - $14,234	-1,241 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$6.44 - $11.32 $180 - $316	-28 Reduced 2.21%	1,241 $11,000
Q4 2019 Feb 04, 2020	SELL	$5.26 - $9.6 $68 - $124	-13 Reduced 1.01%	1,269 $12,000
Q3 2019 Nov 12, 2019	BUY	$5.58 - $6.3 $7,153 - $8,076	1,282 New	1,282 $8,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $13.8M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.